Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin as first-line treatment for Chinese patients with ovarian cancer: A multi-center, randomized, open-label trial

被引：0
|
作者：
Shen, Yuanming
Kong, Beihua
Xia, Bairong
Wang, Fei
Yin, Rutie
Li, Qingshui
Yue, Ying
Kang, Shan
He, Liping
Wang, Ke
Meng, Yuanguang
Wang, Shixuan
Qu, Pengpeng
Huang, Xianghua
Guo, Ruixia
Yan, Ping
Pan, Mei
Lou, Ge
Cheng, Wenjun
Xie, Xing
机构：
[1] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Zhejiang, Peoples R China
[2] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[3] Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp 1, Hefei, Peoples R China
[4] Shandong Prov Hosp, Jinan, Peoples R China
[5] Sichuan Univ, West China Univ Hosp 2, Chengdu, Sichuan, Peoples R China
[6] Shandong Canc Hosp & Inst, Jinan, Peoples R China
[7] Jilin Univ, Affiliated Hosp 1, Changchun, Peoples R China
[8] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
[9] Hebei Tumor Hosp, Shijiazhuang, Hebei, Peoples R China
[10] Guizhou Med Univ, Affiliated Canc Hosp, Guiyang, Guizhou, Peoples R China
[11] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
[12] Chinese Peoples Liberat Army Gen Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China
[13] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
[14] Tianjin Cent Hosp Gynecol & Obstet, Tianjin, Peoples R China
[15] Hebei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China
[16] Zhengzhou Univ, Affiliated Hosital 1, Zhengzhou, Peoples R China
[17] Hebei Gen Hosp, Shijiazhuang, Hebei, Peoples R China
[18] Maternal & Child Hlth Hosp Jiangxi Prov, Nanchang, Jiangxi, Peoples R China
[19] Harbin Med Univ, Canc Hosp, Harbin, Heilongjiang, Peoples R China
[20] Jiangsu Prov Hosp, Nanjing, Peoples R China
[21] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5556
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Nivolumab versus gemcitabine or pegylated liposomal doxorubicin for patients with platinum-resistant (advanced or recurrent) ovarian cancer: Open-label, randomized trial in Japan (NINJA trial)
    Omatsu, K.
    Hamanishi, J.
    Katsumata, N.
    Nishio, S.
    Sawada, K.
    Takeuchi, S.
    Aoki, D.
    Fujiwara, K.
    Sugiyama, T.
    Konishi, I.
    ANNALS OF ONCOLOGY, 2020, 31 : S611 - S611
  • [42] Carboplatin plus paclitaxel versus carboplatin plus Stealth liposomal doxorubicin in patients with advanced ovarian cancer (AOC): Preliminary activity results of the MITO-2 randomized multicenter trial
    Pignata, S.
    Scambia, G.
    Savarese, A.
    Breda, E.
    Sorio, R.
    Lombardi, A. Vernaglia
    Gebbia, V.
    Scollo, P.
    Lorusso, D.
    Morabito, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non-Small-Cell Lung Cancer
    Langer, Corey J.
    Novello, Silvia
    Park, Keunchil
    Krzakowski, Maciej
    Karp, Daniel D.
    Mok, Tony
    Benner, Rebecca J.
    Scranton, Judith R.
    Olszanski, Anthony J.
    Jassem, Jacek
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (19) : 2059 - U109
  • [44] A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum-sensitive ovarian cancer (OC): CALYPSO study of the Gynecologic Cancer Intergroup (GCIG)
    Pujade-Lauraine, E.
    Mahner, S.
    Kaern, J.
    Gebski, V.
    Heywood, M.
    Vasey, P.
    Reinthaller, A.
    Vergote, I.
    Pignata, S.
    Ferrero, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [45] A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum-sensitive ovarian cancer (OC): CALYPSO study of the Gynecologic Cancer Intergroup (GCIG)
    Wagner, U.
    Burges, A.
    Kurzeder, C.
    Beckmann, M. W.
    Belau, A.
    Hanker, L.
    Canzler, U.
    Richter, B.
    Sehouli, J.
    Pujade-Lauraine, E.
    ONKOLOGIE, 2010, 33 : 2 - 2
  • [46] A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum- sensitive ovarian cancer (OC): CALYPSO study of the Gynecologic Cancer Intergroup ( GCIG)
    Pujade-Lauraine, E.
    Mahner, S.
    Kaern, J.
    Gebski, V.
    Heywood, M.
    Vasey, P.
    Reinthaller, A.
    Vergote, I.
    Pignata, S.
    Ferrero, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients
    U Wagner
    C Marth
    R Largillier
    J Kaern
    C Brown
    M Heywood
    T Bonaventura
    I Vergote
    M C Piccirillo
    R Fossati
    V Gebski
    E P Lauraine
    British Journal of Cancer, 2012, 107 : 588 - 591
  • [48] Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer
    Ngoi, Natalie Y. L.
    Syn, Nicholas L. X.
    Goh, Robby M.
    Goh, Boon Cher
    Huang, Ruby Yun-Ju
    Soon, Yu Yang
    James, Elizabeth
    Cook, Adrian
    Clamp, Andrew
    Tan, David S. P.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (02):
  • [49] Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients
    Wagner, U.
    Marth, C.
    Largillier, R.
    Kaern, J.
    Brown, C.
    Heywood, M.
    Bonaventura, T.
    Vergote, I.
    Piccirillo, M. C.
    Fossati, R.
    Gebski, V.
    Lauraine, E. P.
    BRITISH JOURNAL OF CANCER, 2012, 107 (04) : 588 - 591
  • [50] Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer
    du Bois, Andreas
    Herrstedt, Jorn
    Hardy-Bessard, Anne-Claire
    Mueller, Hans-Helge
    Harter, Philipp
    Kristensen, Gunnar
    Joly, Florence
    Huober, Jens
    Avall-Lundqvist, Elisabeth
    Weber, Beatrice
    Kurzeder, Christian
    Jelic, Svetislav
    Pujade-Lauraine, Eric
    Burges, Alexander
    Pfisterer, Jacobus
    Gropp, Martina
    Staehle, Anne
    Wimberger, Pauline
    Jackisch, Christian
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) : 4162 - 4169
12345